Precigen, Inc. stock is up 3.6% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 54.55% of the previous 10 February’s closed higher than January.
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. The company was formerly known as Intrexon Corporation and changed its name to Precigen in January 2020.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!